Rubella/German measles, also called three-day measles, is a contagious disease caused by a viral infection in children. Rubella causes a red rash and a mild fever in children; however, infection during pregnancy can lead to miscarriage, fetal death, stillbirth, or birth with congenital malformations. Rubella diagnostic testing involves the detection of the rubella virus by techniques like latex slide agglutination test, immunoassays, serological testing, and others.
MARKET DYNAMICS
The rubella diagnostic testing market is anticipated to grow in the forecast, owing to a rising number of rubella cases across the globe, the development of advanced point-of-care diagnostic technologies, and increasing funds for the development of innovative diagnostic techniques. In addition, growing government initiatives to restrict the rubella virus is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Rubella Diagnostic Testing Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of rubella diagnostic testing market with detailed market segmentation by testing technique, application and geography. The rubella diagnostic testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading rubella diagnostic testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The rubella diagnostic testing market is segmented on the basis of testing technique and application. Based on testing technique the market is segmented as serological testing, latex agglutination, enzyme immunoassay (EIA), radioimmunoassay (RIA), fluorescent immunoassay (FIA), and other testing techniques. The application segment is classified into hospitals, laboratories, and other applications.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the rubella diagnostic testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The rubella diagnostic testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting rubella diagnostic testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the rubella diagnostic testing market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the rubella diagnostic testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The rubella diagnostic testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting rubella diagnostic testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the rubella diagnostic testing market in these regions.
MARKET PLAYERS
The report covers key developments in the rubella diagnostic testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Rubella diagnostic testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for rubella diagnostic testing market in the global market. Below mentioned is the list of few companies engaged in the rubella diagnostic testing market.
The report also includes the profiles of key rubella diagnostic testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- ZEUS Scientific Inc.
- Abbott
- Beckman Coulter Inc.
- Bio Rad Laboratories Inc.
- Biokit SA
- bioMérieux SA
- F. Hoffmann-La Roche Ltd
- Ortho Clinical Diagnostics
- Siemens Healthcare GmbH
- Thermo Fisher Scientific
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rubella Diagnostic Testing Market - By Testing Technique
1.3.2 Rubella Diagnostic Testing Market - By Application
1.3.3 Rubella Diagnostic Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RUBELLA DIAGNOSTIC TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RUBELLA DIAGNOSTIC TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. RUBELLA DIAGNOSTIC TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. RUBELLA DIAGNOSTIC TESTING - GLOBAL MARKET OVERVIEW
6.2. RUBELLA DIAGNOSTIC TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RUBELLA DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TESTING TECHNIQUE
7.1. OVERVIEW
7.2. TESTING TECHNIQUE MARKET FORECASTS AND ANALYSIS
7.3. SEROLOGICAL TESTING
7.3.1. Overview
7.3.2. Serological Testing Market Forecast and Analysis
7.4. LATEX AGGLUTINATION
7.4.1. Overview
7.4.2. Latex Agglutination Market Forecast and Analysis
7.5. ENZYME IMMUNOASSAY (EIA)
7.5.1. Overview
7.5.2. Enzyme Immunoassay (EIA) Market Forecast and Analysis
7.6. RADIOIMMUNOASSAY (RIA)
7.6.1. Overview
7.6.2. Radioimmunoassay (RIA) Market Forecast and Analysis
7.7. FLUORESCENT IMMUNOASSAY (FIA)
7.7.1. Overview
7.7.2. Fluorescent Immunoassay (FIA) Market Forecast and Analysis
7.8. OTHER TESTING TECHNIQUES
7.8.1. Overview
7.8.2. Other Testing Techniques Market Forecast and Analysis
8. RUBELLA DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. LABORATORIES
8.4.1. Overview
8.4.2. Laboratories Market Forecast and Analysis
8.5. OTHER APPLICATIONS
8.5.1. Overview
8.5.2. Other Applications Market Forecast and Analysis
9. RUBELLA DIAGNOSTIC TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Rubella Diagnostic Testing Market Overview
9.1.2 North America Rubella Diagnostic Testing Market Forecasts and Analysis
9.1.3 North America Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.1.4 North America Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.1.5 North America Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Rubella Diagnostic Testing Market
9.1.5.1.1 United States Rubella Diagnostic Testing Market by Testing Technique
9.1.5.1.2 United States Rubella Diagnostic Testing Market by Application
9.1.5.2 Canada Rubella Diagnostic Testing Market
9.1.5.2.1 Canada Rubella Diagnostic Testing Market by Testing Technique
9.1.5.2.2 Canada Rubella Diagnostic Testing Market by Application
9.1.5.3 Mexico Rubella Diagnostic Testing Market
9.1.5.3.1 Mexico Rubella Diagnostic Testing Market by Testing Technique
9.1.5.3.2 Mexico Rubella Diagnostic Testing Market by Application
9.2. EUROPE
9.2.1 Europe Rubella Diagnostic Testing Market Overview
9.2.2 Europe Rubella Diagnostic Testing Market Forecasts and Analysis
9.2.3 Europe Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.2.4 Europe Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.2.5 Europe Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Rubella Diagnostic Testing Market
9.2.5.1.1 Germany Rubella Diagnostic Testing Market by Testing Technique
9.2.5.1.2 Germany Rubella Diagnostic Testing Market by Application
9.2.5.2 France Rubella Diagnostic Testing Market
9.2.5.2.1 France Rubella Diagnostic Testing Market by Testing Technique
9.2.5.2.2 France Rubella Diagnostic Testing Market by Application
9.2.5.3 Italy Rubella Diagnostic Testing Market
9.2.5.3.1 Italy Rubella Diagnostic Testing Market by Testing Technique
9.2.5.3.2 Italy Rubella Diagnostic Testing Market by Application
9.2.5.4 Spain Rubella Diagnostic Testing Market
9.2.5.4.1 Spain Rubella Diagnostic Testing Market by Testing Technique
9.2.5.4.2 Spain Rubella Diagnostic Testing Market by Application
9.2.5.5 United Kingdom Rubella Diagnostic Testing Market
9.2.5.5.1 United Kingdom Rubella Diagnostic Testing Market by Testing Technique
9.2.5.5.2 United Kingdom Rubella Diagnostic Testing Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Rubella Diagnostic Testing Market Overview
9.3.2 Asia-Pacific Rubella Diagnostic Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.3.4 Asia-Pacific Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Rubella Diagnostic Testing Market
9.3.5.1.1 Australia Rubella Diagnostic Testing Market by Testing Technique
9.3.5.1.2 Australia Rubella Diagnostic Testing Market by Application
9.3.5.2 China Rubella Diagnostic Testing Market
9.3.5.2.1 China Rubella Diagnostic Testing Market by Testing Technique
9.3.5.2.2 China Rubella Diagnostic Testing Market by Application
9.3.5.3 India Rubella Diagnostic Testing Market
9.3.5.3.1 India Rubella Diagnostic Testing Market by Testing Technique
9.3.5.3.2 India Rubella Diagnostic Testing Market by Application
9.3.5.4 Japan Rubella Diagnostic Testing Market
9.3.5.4.1 Japan Rubella Diagnostic Testing Market by Testing Technique
9.3.5.4.2 Japan Rubella Diagnostic Testing Market by Application
9.3.5.5 South Korea Rubella Diagnostic Testing Market
9.3.5.5.1 South Korea Rubella Diagnostic Testing Market by Testing Technique
9.3.5.5.2 South Korea Rubella Diagnostic Testing Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Rubella Diagnostic Testing Market Overview
9.4.2 Middle East and Africa Rubella Diagnostic Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.4.4 Middle East and Africa Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Rubella Diagnostic Testing Market
9.4.5.1.1 South Africa Rubella Diagnostic Testing Market by Testing Technique
9.4.5.1.2 South Africa Rubella Diagnostic Testing Market by Application
9.4.5.2 Saudi Arabia Rubella Diagnostic Testing Market
9.4.5.2.1 Saudi Arabia Rubella Diagnostic Testing Market by Testing Technique
9.4.5.2.2 Saudi Arabia Rubella Diagnostic Testing Market by Application
9.4.5.3 U.A.E Rubella Diagnostic Testing Market
9.4.5.3.1 U.A.E Rubella Diagnostic Testing Market by Testing Technique
9.4.5.3.2 U.A.E Rubella Diagnostic Testing Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South & Central America Rubella Diagnostic Testing Market Overview
9.5.2 South & Central America Rubella Diagnostic Testing Market Forecasts and Analysis
9.5.3 South & Central America Rubella Diagnostic Testing Market Forecasts and Analysis - By Testing Technique
9.5.4 South & Central America Rubella Diagnostic Testing Market Forecasts and Analysis - By Application
9.5.5 South & Central America Rubella Diagnostic Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Rubella Diagnostic Testing Market
9.5.5.1.1 Brazil Rubella Diagnostic Testing Market by Testing Technique
9.5.5.1.2 Brazil Rubella Diagnostic Testing Market by Application
9.5.5.2 Argentina Rubella Diagnostic Testing Market
9.5.5.2.1 Argentina Rubella Diagnostic Testing Market by Testing Technique
9.5.5.2.2 Argentina Rubella Diagnostic Testing Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. RUBELLA DIAGNOSTIC TESTING MARKET, KEY COMPANY PROFILES
11.1. ZEUS SCIENTIFIC INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ABBOTT
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BECKMAN COULTER INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIO RAD LABORATORIES INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIOKIT SA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIOMéRIEUX SA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. F. HOFFMANN-LA ROCHE LTD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ORTHO CLINICAL DIAGNOSTICS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SIEMENS HEALTHCARE GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. THERMO FISHER SCIENTIFIC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. ZEUS Scientific Inc.
2. Abbott
3. Beckman Coulter Inc.
4. Bio Rad Laboratories Inc.
5. Biokit SA
6. bioMérieux SA
7. F. Hoffmann-La Roche Ltd
8. Ortho Clinical Diagnostics
9. Siemens Healthcare GmbH
10. Thermo Fisher Scientific
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For